BPI20-019: Pooled Analysis of Phase 3 Studies Comparing a Single-Dose Fixed Combination of Netupitant / Palonosetron (NEPA) vs a 3-Day Aprepitant-Based Regimen (APR) for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC)

Authors:
Rudolph M. Navari University of Alabama at Birmingham, Birmingham, AL

Search for other papers by Rudolph M. Navari in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Erminio Bonizzoni University of Milan, Milan, Italy

Search for other papers by Erminio Bonizzoni in
Current site
Google Scholar
PubMed Close
 PhD
,
Rita Wickham Rush University College of Nursing, Chicago, IL

Search for other papers by Rita Wickham in
Current site
Google Scholar
PubMed Close
 PhD, MS, BSN
, and
Rebecca Clark-Snow Oncology Supportive Care Consultant, Overland Park, KS

Search for other papers by Rebecca Clark-Snow in
Current site
Google Scholar
PubMed Close
 RN, BSN, OCN
Volume/Issue:
Volume 18: Issue 3.5
Online Publication Date:
20 Mar 2020
DOI:
https://doi.org/10.6004/jnccn.2019.7430
Restricted access

Corresponding Author: Rudolph M. Navari, MD, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2020 by the National Comprehensive Cancer Network 2020
Article Category:
Abstract
Print Publication Date:
20 Mar 2020
Online Publication Date:
20 Mar 2020

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1047 300 61
PDF Downloads 525 0 0
EPUB Downloads 0 0 0